174 related articles for article (PubMed ID: 21624390)
1. N-methyl-D-aspartate receptor antagonist MK-801 suppresses glial pro-inflammatory cytokine expression in morphine-tolerant rats.
Liu CH; Cherng CH; Lin SL; Yeh CC; Wu CT; Tai YH; Wong CS
Pharmacol Biochem Behav; 2011 Sep; 99(3):371-80. PubMed ID: 21624390
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol regulates N-methyl-D-aspartate receptor expression and suppresses neuroinflammation in morphine-tolerant rats.
Tsai RY; Chou KY; Shen CH; Chien CC; Tsai WY; Huang YN; Tao PL; Lin YS; Wong CS
Anesth Analg; 2012 Oct; 115(4):944-52. PubMed ID: 22713680
[TBL] [Abstract][Full Text] [Related]
3. Ultra-low dose naloxone upregulates interleukin-10 expression and suppresses neuroinflammation in morphine-tolerant rat spinal cords.
Lin SL; Tsai RY; Tai YH; Cherng CH; Wu CT; Yeh CC; Wong CS
Behav Brain Res; 2010 Feb; 207(1):30-6. PubMed ID: 19799935
[TBL] [Abstract][Full Text] [Related]
4. Purinergic P2X receptor regulates N-methyl-D-aspartate receptor expression and synaptic excitatory amino acid concentration in morphine-tolerant rats.
Tai YH; Cheng PY; Tsai RY; Chen YF; Wong CS
Anesthesiology; 2010 Nov; 113(5):1163-75. PubMed ID: 20938337
[TBL] [Abstract][Full Text] [Related]
5. Lipoxin A4 analog attenuates morphine antinociceptive tolerance, withdrawal-induced hyperalgesia, and glial reaction and cytokine expression in the spinal cord of rat.
Jin H; Li YH; Xu JS; Guo GQ; Chen DL; Bo Y
Neuroscience; 2012 Apr; 208():1-10. PubMed ID: 22366510
[TBL] [Abstract][Full Text] [Related]
6. Co-administration of ultra-low dose naloxone attenuates morphine tolerance in rats via attenuation of NMDA receptor neurotransmission and suppression of neuroinflammation in the spinal cords.
Lin SL; Tsai RY; Shen CH; Lin FH; Wang JJ; Hsin ST; Wong CS
Pharmacol Biochem Behav; 2010 Aug; 96(2):236-45. PubMed ID: 20478329
[TBL] [Abstract][Full Text] [Related]
7. Repetitive opioid abstinence causes progressive hyperalgesia sensitive to N-methyl-D-aspartate receptor blockade in the rat.
Dunbar SA; Pulai IJ
J Pharmacol Exp Ther; 1998 Feb; 284(2):678-86. PubMed ID: 9454814
[TBL] [Abstract][Full Text] [Related]
8. Amitriptyline attenuates astrocyte activation and morphine tolerance in rats: role of the PSD-95/NR1/nNOS/PKCγ signaling pathway.
Huang YN; Tsai RY; Lin SL; Chien CC; Cherng CH; Wu CT; Yeh CC; Wong CS
Behav Brain Res; 2012 Apr; 229(2):401-11. PubMed ID: 22309983
[TBL] [Abstract][Full Text] [Related]
9. N-Methyl-D-aspartate receptor antagonist MK-801 attenuates morphine tolerance and associated glial fibrillary acid protein up-regulation: a proteomic approach.
Wen ZH; Wu GJ; Hsu LC; Chen WF; Chen JY; Shui HA; Chou AK; Wong CS
Acta Anaesthesiol Scand; 2008 Apr; 52(4):499-508. PubMed ID: 18339156
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
Boronat MA; Olmos G; García-Sevilla JA
Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of morphine analgesia by LPS: role of opioid and NMDA receptors and spinal glia.
Johnston IN; Westbrook RF
Behav Brain Res; 2005 Jan; 156(1):75-83. PubMed ID: 15474652
[TBL] [Abstract][Full Text] [Related]
12. Amitriptyline suppresses neuroinflammation and up-regulates glutamate transporters in morphine-tolerant rats.
Tai YH; Wang YH; Wang JJ; Tao PL; Tung CS; Wong CS
Pain; 2006 Sep; 124(1-2):77-86. PubMed ID: 16697108
[TBL] [Abstract][Full Text] [Related]
13. Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614.
Tiseo PJ; Inturrisi CE
J Pharmacol Exp Ther; 1993 Mar; 264(3):1090-6. PubMed ID: 8450453
[TBL] [Abstract][Full Text] [Related]
14. The NMDA antagonist MK-801 induces hyperalgesia and increases CSF excitatory amino acids in rats: reversal by guanosine.
Schmidt AP; Tort AB; Silveira PP; Böhmer AE; Hansel G; Knorr L; Schallenberger C; Dalmaz C; Elisabetsky E; Crestana RH; Lara DR; Souza DO
Pharmacol Biochem Behav; 2009 Feb; 91(4):549-53. PubMed ID: 18854198
[TBL] [Abstract][Full Text] [Related]
15. Antagonism of N-methyl-D-aspartate receptors reduces the vulnerability of the immune system to stress after chronic morphine.
Alonzo NC; Bayer BM
J Pharmacol Exp Ther; 2003 Nov; 307(2):793-800. PubMed ID: 12966157
[TBL] [Abstract][Full Text] [Related]
16. Are glycineB sites involved in the development of morphine tolerance?
Kotlińska J
Pol J Pharmacol; 2004; 56(1):51-7. PubMed ID: 15047977
[TBL] [Abstract][Full Text] [Related]
17. Etanercept restores the antinociceptive effect of morphine and suppresses spinal neuroinflammation in morphine-tolerant rats.
Shen CH; Tsai RY; Shih MS; Lin SL; Tai YH; Chien CC; Wong CS
Anesth Analg; 2011 Feb; 112(2):454-9. PubMed ID: 21081778
[TBL] [Abstract][Full Text] [Related]
18. The NMDA receptor antagonist MK-801 protects against the development of morphine tolerance after intrathecal administration.
Kest B; Mogil JS; Shamgar BE; Kao B; Liebeskind JC; Marek P
Proc West Pharmacol Soc; 1993; 36():307-10. PubMed ID: 8378393
[No Abstract] [Full Text] [Related]
19. Dextromethorphan potentiates morphine antinociception at the spinal level in rats.
Chow LH; Huang EY; Ho ST; Lee TY; Tao PL
Can J Anaesth; 2004 Nov; 51(9):905-10. PubMed ID: 15525615
[TBL] [Abstract][Full Text] [Related]
20. Increasing of intrathecal CSF excitatory amino acids concentration following morphine challenge in morphine-tolerant rats.
Wen ZH; Chang YC; Cherng CH; Wang JJ; Tao PL; Wong CS
Brain Res; 2004 Jan; 995(2):253-9. PubMed ID: 14672815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]